Turkey · Delayed Price · Currency is TRY IST:BIOEN Statistics
Total Valuation
IST:BIOEN has a market cap or net worth of TRY 8.94 billion. The enterprise value is 14.67 billion.
| Market Cap | 8.94B |
| Enterprise Value | 14.67B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:BIOEN has 500.00 million shares outstanding.
| Current Share Class | 500.00M |
| Shares Outstanding | 500.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 15.12% |
| Float | 197.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.16 |
| PB Ratio | 2.73 |
| P/TBV Ratio | 3.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 20.32 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.19 |
| EV / EBITDA | 166.76 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 1.79.
| Current Ratio | 0.37 |
| Quick Ratio | 0.17 |
| Debt / Equity | 1.79 |
| Debt / EBITDA | 27.70 |
| Debt / FCF | -95.00 |
| Interest Coverage | -1.25 |
Financial Efficiency
Return on equity (ROE) is -23.33% and return on invested capital (ROIC) is -5.12%.
| Return on Equity (ROE) | -23.33% |
| Return on Assets (ROA) | -4.48% |
| Return on Invested Capital (ROIC) | -5.12% |
| Return on Capital Employed (ROCE) | -8.60% |
| Weighted Average Cost of Capital (WACC) | 5.98% |
| Revenue Per Employee | 3.46M |
| Profits Per Employee | -1.05M |
| Employee Count | 818 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 9.47 |
Taxes
In the past 12 months, IST:BIOEN has paid 292.47 million in taxes.
| Income Tax | 292.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.41% in the last 52 weeks. The beta is 0.10, so IST:BIOEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -18.41% |
| 50-Day Moving Average | 18.35 |
| 200-Day Moving Average | 19.24 |
| Relative Strength Index (RSI) | 48.81 |
| Average Volume (20 Days) | 16,042,888 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:BIOEN had revenue of TRY 2.83 billion and -860.82 million in losses. Loss per share was -1.72.
| Revenue | 2.83B |
| Gross Profit | -73.02M |
| Operating Income | -721.93M |
| Pretax Income | -568.35M |
| Net Income | -860.82M |
| EBITDA | 87.92M |
| EBIT | -721.93M |
| Loss Per Share | -1.72 |
Balance Sheet
The company has 131.62 million in cash and 5.87 billion in debt, with a net cash position of -5.73 billion or -11.47 per share.
| Cash & Cash Equivalents | 131.62M |
| Total Debt | 5.87B |
| Net Cash | -5.73B |
| Net Cash Per Share | -11.47 |
| Equity (Book Value) | 3.27B |
| Book Value Per Share | 6.55 |
| Working Capital | -1.63B |
Cash Flow
In the last 12 months, operating cash flow was 439.81 million and capital expenditures -501.54 million, giving a free cash flow of -61.74 million.
| Operating Cash Flow | 439.81M |
| Capital Expenditures | -501.54M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 538.31M |
| Free Cash Flow | -61.74M |
| FCF Per Share | -0.12 |
Margins
Gross margin is -2.58%, with operating and profit margins of -25.53% and -30.44%.
| Gross Margin | -2.58% |
| Operating Margin | -25.53% |
| Pretax Margin | -20.10% |
| Profit Margin | -30.44% |
| EBITDA Margin | 3.11% |
| EBIT Margin | -25.53% |
| FCF Margin | n/a |
Dividends & Yields
IST:BIOEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.63% |
| FCF Yield | -0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 24, 2021. It was a forward split with a ratio of 3.3333333.
| Last Split Date | Nov 24, 2021 |
| Split Type | Forward |
| Split Ratio | 3.3333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |